Status:
COMPLETED
AFF008E: Observational Phase 1b Follow-up Extension Study for Patients With Parkinson's Disease After Immunization With AFFITOPE® PD01A
Lead Sponsor:
Affiris AG
Conditions:
Parkinson's Disease
Eligibility:
All Genders
41-66 years
Brief Summary
AFF008E is set-up to assess the long term effects of the 4 PD01A vaccinations that have been applied during AFF008 with regard to safety as well as immunological-, radiological and clinical activity. ...
Eligibility Criteria
Inclusion
- Written informed consent signed and dated by the patient
- Participation in AFF008
Exclusion
- History of questionable compliance to visit schedule; patients not expected to complete the clinical trial
- Participation in the active treatment phase of another clinical trial except AFF008 within 13 weeks before Visit 1 and for the whole study duration
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01885494
Start Date
June 1 2013
Last Update
August 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität-Privatklinik Josefstadt, Skodagasse 32
Vienna, Austria, 1080